Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes

Molecular and histopathological analysis of melanoma subtypes has revealed distinct epidemiological, genetic, and clinical features. However, immunotherapy for advanced metastatic melanoma patients does not differ based on subtype. Response to immune checkpoint inhibitors (ICI) has been shown to var...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrieu, Charlotte, McNamee, Niamh, Larkin, Anne-Marie, Maguire, Alanna, Menon, Roopika, Mueller-Eisert, Judith, Horgan, Noel, Kennedy, Susan, Gullo, Giuseppe, Crown, John, Walsh, Naomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230974/
https://www.ncbi.nlm.nih.gov/pubmed/35736346
http://dx.doi.org/10.3390/medsci10020026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230974/
https://www.ncbi.nlm.nih.gov/pubmed/35736346
http://dx.doi.org/10.3390/medsci10020026

Ejemplares similares